159
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Relapsed Acute Promyelocytic Leukemia Previously Treated with All-Trans Retinoic Acid: Clinical Experience with a New Synthetic Retinoid, Am-80

, , , , , , , & show all
Pages 441-451 | Accepted 22 Dec 1997, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chao Yuan, Yu-Sheng Zhang, Yan-Na Cheng, Xia Xue, Wen-Fang Xu & Xian-Jun Qu. (2012) A112, a tamibarotene dimethylaminoethyl ester, may inhibit human leukemia cell growth more potently than tamibarotene. Leukemia & Lymphoma 53:2, pages 295-304.
Read now

Articles from other publishers (27)

Aroa Duro-Castano, Diana Moreira Leite, Joe Forth, Yangwei Deng, Diana Matias, Carlos Noble Jesus & Giuseppe Battaglia. (2020) Designing peptide nanoparticles for efficient brain delivery. Advanced Drug Delivery Reviews 160, pages 52-77.
Crossref
Hisham Abdel-Azim, Weili Sun & Lingtao Wu. (2019) Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy. Pharmacology & Therapeutics 204, pages 107403.
Crossref
Marta Melis, Xiao-Han Tang, Steven E. Trasino, Viral M. Patel, Daniel J. Stummer, Jose Jessurun & Lorraine J. Gudas. (2019) Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease. PLOS ONE 14:1, pages e0211071.
Crossref
Norio Asou. 2017. Chemotherapy for Leukemia. Chemotherapy for Leukemia 183 211 .
Xianghong Guan, Peihua Luo, Qiaojun He, Yongzhou Hu & Huazhou Ying. (2016) Design, Synthesis and Evaluation of Indene Derivatives as Retinoic Acid Receptor α Agonists. Molecules 22:1, pages 32.
Crossref
David Sanford, Francesco Lo-Coco, Miguel A. Sanz, Eros Di Bona, Steven Coutre, Jessica K. Altman, Meir Wetzler, Steven L. Allen, Farhad Ravandi, Hagop Kantarjian & Jorge E. Cortes. (2015) Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all- trans retinoic acid and arsenic trioxide . British Journal of Haematology 171:4, pages 471-477.
Crossref
Akihiro Tomita, Hitoshi Kiyoi & Tomoki Naoe. (2013) Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia. International Journal of Hematology 97:6, pages 717-725.
Crossref
Hiroyuki Tsuchiya, Yoshito Ikeda, Yu Ebata, Chihiro Kojima, Rikutaro Katsuma, Tatsuaki Tsuruyama, Tomohiko Sakabe, Kohei Shomori, Noriko Komeda, Shoko Oshiro, Hideharu Okamoto, Kazuko Takubo, Susumu Hama, Koichi Shudo, Kentaro Kogure & Goshi Shiota. (2012) Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice. Hepatology 56:4, pages 1319-1330.
Crossref
Hiroyuki Tsuchiya. (2012) Retinoids as Promising Treatment for Non-alcoholic Fatty Liver Disease非アルコール性脂肪性肝疾患治療薬としてのレチノイドの有用性. YAKUGAKU ZASSHI 132:8, pages 903-909.
Crossref
Kinya Ohata, Hirohito Yamazaki, Hidesaku Asakura, Shigeru Shimadoi & Shinji Nakao. (2012) Tamibarotene-induced low-grade reversible intravascular coagulation in a patient with acute promyelocytic leukemia. Thrombosis Research 129:2, pages 213-214.
Crossref
Donald J. AbrahamMarcia I. Dawson. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 369 546 .
Martin S. Tallman & Jessica K. Altman. (2009) How I treat acute promyelocytic leukemia. Blood 114:25, pages 5126-5135.
Crossref
Jane A. Pinaire & Anne Reifel-Miller. (2007) Therapeutic Potential of Retinoid X Receptor Modulators for the Treatment of the Metabolic Syndrome. PPAR Research 2007, pages 1-12.
Crossref
N.T. Zaveri & B.J. Murphy. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II 993 1036 .
Pierre Germain, Pierre Chambon, Gregor Eichele, Ronald M. Evans, Mitchell A. Lazar, Mark Leid, Angel R. De Lera, Reuben Lotan, David J. Mangelsdorf & Hinrich Gronemeyer. (2006) International Union of Pharmacology. LX. Retinoic Acid Receptors. Pharmacological Reviews 58:4, pages 712-725.
Crossref
Seiichi Ishida, Yukari Shigemoto-Mogami, Youichi Shinozaki, Hiroyuki Kagechika, Koichi Shudo, Shogo Ozawa, Jun-ichi Sawada, Yasuo Ohno & Kazuhide Inoue. (2004) Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochemical Pharmacology 68:11, pages 2177-2186.
Crossref
. (2003) 転写因子KLF5/BTEB2の心血管リモデリングにおける意義(1.心筋リモデリングの分子メカニズムと治療への展開)(<特集>第67回日本循環器学会学術集会). Journal of JCS Cardiologists 11:2, pages 229-234.
Crossref
F.Christopher Zusi, Matthew V Lorenzi & Valerie Vivat-Hannah. (2002) Selective retinoids and rexinoids in cancer therapy and chemoprevention. Drug Discovery Today 7:23, pages 1165-1174.
Crossref
Xavier Thomas. (2002) Nouvelles approches thérapeutiques des leucémies aiguës de l'adulte. Revue Française des Laboratoires 2002:344, pages 55-65.
Crossref
Wilson H Miller Jr & Samuel Waxman. (2002) Differentiation induction as a treatment for hematologic malignancies. Oncogene 21:21, pages 3496-3506.
Crossref
Bulent Ozpolat, Kapil Mehta, Ana M. Tari & Gabriel Lopez‐Berestein. (2002) all‐trans ‐Retinoic acid‐induced expression and regulation of retinoic acid 4‐hydroxylase (CYP26) in human promyelocytic leukemia . American Journal of Hematology 70:1, pages 39-47.
Crossref
Dan Douer. (2002) New advances in the treatment of acute promyelocytic leukemia. International Journal of Hematology 76:S2, pages 179-187.
Crossref
Francis J. Giles, Armand Keating, Anthony H. Goldstone, Irit Avivi, Cheryl L. Willman & Hagop M. Kantarjian. (2002) Acute Myeloid Leukemia. Hematology 2002:1, pages 73-110.
Crossref
M.S. Tallman. (2001) Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies. Blood Reviews 15:3, pages 133-142.
Crossref
Pierre Fenaux, Christine Chomienne & Laurent Degos. (2001) Treatment of acute promyelocytic leukaemia. Best Practice & Research Clinical Haematology 14:1, pages 153-174.
Crossref
Peter J. A. Davies, Stacey A. Berry, Gregory L. Shipley, Robert H. Eckel, Nathalie Hennuyer, Diane L. Crombie, Kathleen M. Ogilvie, Julia Peinado-Onsurbe, Catherine Fievet, Mark D. Leibowitz, Richard A. Heyman & Johan Auwerx. (2001) Metabolic Effects of Rexinoids: Tissue-Specific Regulation of Lipoprotein Lipase Activity. Molecular Pharmacology 59:2, pages 170-176.
Crossref
Pierre Fenaux, Christine Chomienne & Lament Degos. (2001) All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Seminars in Hematology 38:1, pages 13-25.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.